Retraction and republication-Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Lancet Respir Med. 2024 Apr;12(4):262-263. doi: 10.1016/S2213-2600(24)00029-8.
No abstract available

Publication types

  • Retraction of Publication